160 related articles for article (PubMed ID: 1315227)
1. IL-6 in malignant pleural effusions and its augmentation by intrapleural instillation of IL-2.
Yanagawa H; Sone S; Munekata M; Atagi S; Nii A; Ogura T
Clin Exp Immunol; 1992 May; 88(2):207-12. PubMed ID: 1315227
[TBL] [Abstract][Full Text] [Related]
2. Macrophage colony-stimulating factor activity in malignant pleural effusions. Its augmentation by intrapleural interleukin-2 infusions.
Sone S; Nakanishi M; Ohmoto Y; Yanagawa H; Ogura T
Chest; 1991 Feb; 99(2):377-81. PubMed ID: 1989799
[TBL] [Abstract][Full Text] [Related]
3. [Induction by local injections of IL-2 of antitumor effector cells and secondary production of cytokines in malignant pleural effusion].
Sone S; Yanagawa H; Nii A; Ozaki T; Ogura T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1434-40. PubMed ID: 1434216
[TBL] [Abstract][Full Text] [Related]
4. Correlation between DNA content, expression of Ki-67 antigen of tumor cells and immunophenotype of lymphocytes from malignant pleural effusions.
Sikora J; Dworacki G; Trybus M; Batura-Gabryel H; Zeromski J
Tumour Biol; 1998; 19(3):196-204. PubMed ID: 9591046
[TBL] [Abstract][Full Text] [Related]
5. Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer.
Yasumoto K; Mivazaki K; Nagashima A; Ishida T; Kuda T; Yano T; Sugimachi K; Nomoto K
Cancer Res; 1987 Apr; 47(8):2184-7. PubMed ID: 3493843
[TBL] [Abstract][Full Text] [Related]
6. Previous Radiotherapy Increases the Efficacy of IL-2 in Malignant Pleural Effusion: Potential Evidence of a Radio-Memory Effect?
Chen D; Song X; Wang H; Gao Z; Meng W; Chen S; Ma Y; Wang Y; Li K; Yu J; Yue J
Front Immunol; 2018; 9():2916. PubMed ID: 30619280
[TBL] [Abstract][Full Text] [Related]
7. Effect of IL-6 elevation in malignant pleural effusion on hyperfibrinogenemia in lung cancer patients.
Yamaguchi T; Kimura H; Yokota S; Yamamoto Y; Hashimoto T; Nakagawa M; Ito M; Ogura T
Jpn J Clin Oncol; 2000 Feb; 30(2):53-8. PubMed ID: 10768866
[TBL] [Abstract][Full Text] [Related]
8. T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions.
Okamoto M; Hasegawa Y; Hara T; Hashimoto N; Imaizumi K; Shimokata K; Kawabe T
Chest; 2005 Dec; 128(6):4030-5. PubMed ID: 16354877
[TBL] [Abstract][Full Text] [Related]
9. [Colony-stimulating factor activity in malignant pleural effusions and its augmentation by local administration of interleukin 2].
Nakanishi M; Sone S; Ogura T
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jul; 29(7):824-8. PubMed ID: 1920977
[TBL] [Abstract][Full Text] [Related]
10. Changes in cell population and tumor necrosis factor, interleukin-6, and interleukin-8 in malignant pleural effusions after treatment with intrapleural tetracycline.
Lin CC; Liu CC; Lin CY
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1503-6. PubMed ID: 8503562
[TBL] [Abstract][Full Text] [Related]
11. Intrapleural therapy with MDP-Lys (L18), a synthetic derivative of muramyl dipeptide, against malignant pleurisy associated with lung cancer.
Yanagawa H; Haku T; Takeuchi E; Suzuki Y; Nokihara H; Sone S
Lung Cancer; 2000 Feb; 27(2):67-73. PubMed ID: 10688489
[TBL] [Abstract][Full Text] [Related]
12. Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: interleukin-15 vs. interleukin-2.
Chen YM; Ting CC; Peng JW; Yang WK; Yang KY; Tsai CM; Perng RP
J Interferon Cytokine Res; 2000 Jan; 20(1):31-9. PubMed ID: 10670650
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer.
Yanagawa H; Takeuchi E; Suzuki Y; Ohmoto Y; Bando H; Sone S
Cancer Immunol Immunother; 1999 Oct; 48(7):396-400. PubMed ID: 10501853
[TBL] [Abstract][Full Text] [Related]
14. Effect of postoperative intrapleural instillations of interleukin-2 in patients with malignant pleurisy due to lung cancer.
Yasumoto K; Nagashima A; Nakahashi H; Ishida T; Sugimachi K; Nomoto K
Biotherapy; 1993; 6(2):133-8. PubMed ID: 8398572
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-2-administration intravenously and intrapleurally in a patient with primary pulmonary adenocarcinoma. Cellular responses in peripheral blood, intrapleural fluid and bronchoalveolar lavage.
Bjermer L; Grönberg H; Roos G; Henriksson R
Biotherapy; 1993; 6(1):1-7. PubMed ID: 8507539
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma.
DeLong P; Carroll RG; Henry AC; Tanaka T; Ahmad S; Leibowitz MS; Sterman DH; June CH; Albelda SM; Vonderheide RH
Cancer Biol Ther; 2005 Mar; 4(3):342-6. PubMed ID: 15846066
[TBL] [Abstract][Full Text] [Related]
17. Intrapleural administration of recombinant interleukin-2 in non-small cell lung cancer with neoplastic pleural effusion.
Masotti A; Fumagalli L; Morandini GC
Monaldi Arch Chest Dis; 1997 Jun; 52(3):225-8. PubMed ID: 9270246
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC.
Mantovani G; Macciò A; Versace R; Pisano M; Lai P; Esu S; Ghiani M; Dessì D; Turnu E; Santona MC
J Mol Med (Berl); 1995 Aug; 73(8):409-16. PubMed ID: 8528743
[TBL] [Abstract][Full Text] [Related]
19. Intrapleural instillation of interferon gamma in patients with malignant pleurisy due to lung cancer.
Yanagawa H; Haku T; Hiramatsu K; Nokihara H; Takeuchi E; Yano S; Hanibuchi M; Sone S
Cancer Immunol Immunother; 1997 Oct; 45(2):93-9. PubMed ID: 9390200
[TBL] [Abstract][Full Text] [Related]
20. Intrapleural application of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. A multi-institutional cooperative study.
Yasumoto K; Ogura T
Biotherapy; 1991; 3(4):345-9. PubMed ID: 1786198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
